本页面由Tiger Trade Technology Pte. Ltd.提供服务

Reneo Pharmaceuticals, Inc.

18.20
0.0000
成交量:- -
成交额:79.46万
市值:6,084.04万
市盈率:-10.81
高:18.20
开:18.20
低:18.20
收:18.20
52周最高:18.20
52周最低:0.9801
股本:334.29万
流通股本:110.30万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.6843
每股收益(LYR):-2.5227
净资产收益率:-54.00%
总资产收益率:-33.72%
市净率:0.79
市盈率(LYR):-7.21

数据加载中...

2024/10/11

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/11

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/11

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/11

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/10

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/10

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/09

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/09

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/08

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/08

重要事件披露

Form 8-K - Current report
2024/10/02

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/10/02

重要事件披露

Form 8-K - Current report
2024/09/26

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/20

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/09/20

重要事件披露

Form 8-K - Current report
2024/09/13

重要事件披露

Form 8-K - Current report
2024/08/24

SEC问询函

Form CORRESP - Correspondence
2024/08/19

SEC问询函

Form CORRESP - Correspondence
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report